Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Endoscopy segment offers automated endoscope reprocessing systems; infectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets, transport systems, and mobile medical carts; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services.
Read More…
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Phone973-890-7220
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$918.16 million
Profitability
Miscellaneous
Employees2,775
Next Earnings DateN/A
OptionableOptionable
Cantel Medical (NYSE:CMD) Frequently Asked Questions
What is Cantel Medical's stock symbol?
Cantel Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "CMD."
How often does Cantel Medical pay dividends? What is the dividend yield for Cantel Medical?
Cantel Medical announced a Semi-Annual dividend on Wednesday, June 26th. Shareholders of record on Wednesday, July 17th will be paid a dividend of $0.10 per share on Wednesday, July 31st. The ex-dividend date of this dividend is Tuesday, July 16th. View Cantel Medical's Dividend History.
How were Cantel Medical's earnings last quarter?
Cantel Medical Corp. (NYSE:CMD) announced its earnings results on Monday, September, 23rd. The company reported $0.63 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.61 by $0.02. The firm had revenue of $239.48 million for the quarter, compared to analysts' expectations of $238.60 million. Cantel Medical had a return on equity of 15.34% and a net margin of 5.99%. View Cantel Medical's Earnings History.
What is the consensus analysts' recommendation for Cantel Medical?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cantel Medical in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cantel Medical.
Has Cantel Medical been receiving favorable news coverage?
News stories about CMD stock have been trending very negative this week, according to InfoTrie Sentiment. The research firm rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Cantel Medical earned a news impact score of -3.2 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Cantel Medical.
Are investors shorting Cantel Medical?
Cantel Medical saw a increase in short interest during the month of October. As of October 31st, there was short interest totalling 4,920,000 shares, an increase of 19.4% from the September 30th total of 4,120,000 shares. Based on an average daily trading volume, of 283,400 shares, the short-interest ratio is currently 17.4 days. Currently, 12.9% of the shares of the company are short sold. View Cantel Medical's Current Options Chain.
Who are some of Cantel Medical's key competitors?
Some companies that are related to Cantel Medical include Insulet (PODD), ABIOMED (ABMD), Novocure (NVCR), Hill-Rom (HRC), Haemonetics (HAE), Penumbra (PEN), Globus Medical (GMED), Integra Lifesciences (IART), NuVasive (NUVA), ICU Medical (ICUI), Tandem Diabetes Care (TNDM), Nevro (NVRO), Glaukos (GKOS), Irhythm Technologies (IRTC) and Cardiovascular Systems (CSII).
What other stocks do shareholders of Cantel Medical own?
Who are Cantel Medical's key executives?
Cantel Medical's management team includes the folowing people:
- Mr. Charles M. Diker, Chairman and Member of Office of the Chairman (Age 84)
- Mr. George L. Fotiades, Pres, CEO & Vice Chairman (Age 65)
- Mr. Peter G. Clifford, Exec. VP, CFO & Member of Office of the Chairman (Age 49)
- Mr. Eric W. Nodiff, Exec. VP, Gen. Counsel, Corp. Sec. & Member of Office of the Chairman (Age 62)
- Mr. Seth M. Yellin, Exec. VP of Strategy & Corp. Devel. and Member of Office of the Chairman (Age 45)
How do I buy shares of Cantel Medical?
Shares of CMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Cantel Medical's stock price today?
One share of CMD stock can currently be purchased for approximately $71.62.
How big of a company is Cantel Medical?
Cantel Medical has a market capitalization of $2.99 billion and generates $918.16 million in revenue each year. The company earns $55.04 million in net income (profit) each year or $2.37 on an earnings per share basis. Cantel Medical employs 2,775 workers across the globe.View Additional Information About Cantel Medical.
What is Cantel Medical's official website?
How can I contact Cantel Medical?
Cantel Medical's mailing address is 150 CLOVE ROAD, LITTLE FALLS NJ, 07424. The company can be reached via phone at 973-890-7220 or via email at [email protected]
MarketBeat Community Rating for Cantel Medical (NYSE CMD)
MarketBeat's community ratings are surveys of what our community members think about Cantel Medical and other stocks. Vote "Outperform" if you believe CMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
